Implementation of an antimicrobial stewardship program in a hospital is complicated by a variety of challenges. Key issues facing stewardship personnel include recruiting personnel and building relationships, establishing program metrics, selecting stewardship strategies, working with clinicians, reporting results, and adapting the program. These issues can present different challenges at community hospitals and academic medical centers. Strategies for overcoming these challenges require accounting for the unique characteristics of each institution.
DellitT.H., OwensR.C., McGowanJ.E.Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis.2007; 44(2): 159–177.
2.
ASHP statement on the pharmacist's role in antimicrobial stewardship and infection prevention and control. Am J Health Syst Pharm.2010; 67(7): 575–577.
3.
MacDougallC., PolkR.E.Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev.2005; 18(4): 638–656.
4.
OwensR.C.Antimicrobial stewardship: concepts and strategies in the 21st century. Diagn Microbiol Infect Dis.2008; 61(1): 110–128.
5.
PatelD., LawsonW., GuglielmoB.J.Antimicrobial stewardship programs: interventions and associated outcomes. Expert Rev Anti Infect Ther.2008; 6(2): 209–222.
6.
PatersonD.L.The role of antimicrobial management programs in optimizing antibiotic prescribing within hospitals. Clin Infect Dis.2006; 42(Suppl 2): S90–95.
7.
DrewR.H., WhiteR., MacDougallC., HermsenE.D., OwensR.C.Insights from the Society of Infectious Diseases Pharmacists on antimicrobial stewardship guidelines from the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Pharmacotherapy.2009; 29(5): 593–607.
8.
BarlamT.F., DiVallM.Antibiotic-stewardship practices at top academic centers throughout the United States and at hospitals throughout Massachusetts. Infect Control Hosp Epidemiol.2006; 27(7): 695–703.
9.
McQuillenD.P., PetrakR.M., WassermanR.B.The value of infectious diseases specialists: non–patient care activities. Clin Infect Dis.2008; 47(8): 1051–1063.
10.
PakyzA.L., MacDougallC., OinonenM., PolkR.E.Trends in antibacterial use in US academic health centers: 2002 to 2006. Arch. Intern. Med.2008; 168(20): 2254–2260.
11.
CrandonJ.L., KutiJ.L., JonesR.N., NicolauD.P.Comparison of 2002-2006 OPTAMA programs for US hospitals: focus on gram-negative resistance. Ann Pharmacother.2009; 43(2): 220–227.
12.
StyersD., SheehanD.J., HoganP., SahmD.F.Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann Clin Microbiol Antimicrobials.2006; 5(1): 2.
13.
McGregorJ.C., WeekesE., ForrestG.N.Impact of a computerized clinical decision support system on reducing inappropriate antimicrobial use. J Am Med Informatics Assoc.2006; 13(4): 378–384.
14.
GlowackiR.C., SchwartzD.N., ItokazuG.S.Antibiotic combinations with redundant antimicrobial spectra: clinical epidemiology and pilot intervention of computer-assisted surveillance. Clin Infect Dis.2003; 37(1): 59–64.
15.
MerzL.R., WarrenD.K., KollefM.H., FraserV.J.Effects of an antibiotic cycling program on antibiotic prescribing practices in an intensive care unit. Antimicrob Agents Chemother.2004; 48(8): 2861.
16.
GrossR., MorganA.S., KinkyD.E.Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. Clin Infect Dis.2001; 33(3): 289–295.
17.
MertzD., KollerM., HallerP.Outcomes of early switching from intravenous to oral antibiotics on medical wards. J Antimicrob Chemother.2009; 64(1): 188–199.
18.
McGlynnE.A.Introduction and overview of the conceptual framework for a national quality measurement and reporting system. Med Care.2003; 41(1 suppl): I1–7.
19.
JarvisW.R.Benchmarking for prevention: the Centers for Disease Control and Prevention's National Nosocomial Infections Surveillance (NNIS) system experience. Infection.2003; 31(Suppl 2): 44–48.
20.
MacDougallC., PolkR.E.Variability in rates of use of antibacterials among 130 US hospitals and risk-adjustment models for interhospital comparison. Infect Control Hosp Epidemiol.2008; 29(3): 203–211.
21.
Clinical and Laboratory Standards Institute (CLSI).Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement.Wayne, PA: CLSI; 2010.
22.
PappasP.G., KauffmanC.A., AndesD.Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis.2009; 48(5): 503–535.
23.
ChastreJ., WolffM., FagonJ.Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA.2003; 290(19): 2588–2598.
24.
ArnoldF.W., McDonaldL.C., SmithR.S., NewmanD., RamirezJ.A.Improving antimicrobial use in the hospital setting by providing usage feedback to prescribing physicians. Infect Control Hosp Epidemiol.2006; 27(4): 378–382.
25.
HuxJ.E., MeladyM.P., DeBoerD.Confidential prescriber feedback and education to improve antibiotic use in primary care: a controlled trial. CMAJ.1999; 161(4): 388–392.
26.
RegalR.E., DePestelD.D., VandenBusscheH.L.The effect of an antimicrobial restriction program on Pseudomonas aeruginosa resistance to β-lactams in a large teaching hospital. Pharmacotherapy.2003; 23(5): 618–624.
27.
WilcoxM.H.Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea. J Antimicrob Chemother.2004; 54(1): 168–172.
28.
ShardellM., HarrisA.D., El-KamaryS.S.Antimicrobial resistance: statistical analysis and application of quasi experiments to antimicrobial resistance intervention studies. Clin Infect Dis.2007; 45(7): 901–907.
29.
WagnerA.K., SoumeraiS.B., ZhangF., Ross-DegnanD.Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther.2002; 27(4): 299–309. ■
